Award recordCONTRACT

QOL MEDICAL LLC

PIID VA797P15A0006· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2015· $0 net obligations· UEI M1NNLZQB9HA5· FL

Description

2019 PUBLIC LAW UPDATES

Base award description: SPECIALTY BPA - SUCRAID

First action · last action
2014-11-10 · 2018-12-21
Transactions
10
First transaction's obligation
$0
Base + all options value (sum of deltas)
$442,110
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D40204
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 10 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2014-11-10 · this action $0 · running total $0Modification P00001 · 2014-12-31 · this action $0 · running total $0Modification P00002 · 2015-12-21 · this action $0 · running total $0Modification P00003 · 2016-11-11 · this action $0 · running total $0Modification P00005 · 2017-11-06 · this action $0 · running total $0Modification P00006 · 2017-12-14 · this action $0 · running total $0Modification P00007 · 2018-02-01 · this action $0 · running total $0Modification P00008 · 2018-02-01 · this action $0 · running total $0Modification P00009 · 2018-10-15 · this action $0 · running total $0Modification P00010 · 2018-12-21 · this action $0 · running total $0
  • Base2014-11-10+$0= $0
  • Mod P000012014-12-31+$0= $0
  • Mod P000022015-12-21+$0= $0
  • Mod P000032016-11-11+$0= $0
  • Mod P000052017-11-06+$0= $0
  • Mod P000062017-12-14+$0= $0
  • Mod P000072018-02-01+$0= $0
  • Mod P000082018-02-01+$0= $0
  • Mod P000092018-10-15+$0= $0
  • Mod P000102018-12-21+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2014-11-10+$0$0SPECIALTY BPA - SUCRAID
Mod P00001· OTHER ADMINISTRATIVE ACTION2014-12-31+$0$02015 PUBLIC LAW 102-585 PRICE UPDATE FOR SPECIALTY BPA - SUCRAID
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2015-12-21+$0$02016 PUBLIC LAW 102-585 PRICE UPDATE FOR SPECIALTY BPA - SUCRAID
Mod P00003· EXERCISE AN OPTION2016-11-11+$0$0EXERCISE OPTION YEAR
Mod P00005· EXERCISE AN OPTION2017-11-06+$0$0BPA EXTENSION
Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2017-12-14+$0$02018 PUBLIC LAW UPDATE.
Mod P00007· OTHER ADMINISTRATIVE ACTION2018-02-01+$0$0VENDOR ADDRESS CHANGE
Mod P00008· OTHER ADMINISTRATIVE ACTION2018-02-01+$0$0UPDATE SPECIALTY DISTRIBUTOR AND ORDERING FORMS
Mod P00009· EXERCISE AN OPTION2018-10-15+$0$0EXERCISE 4TH AND FINAL OPTION YEAR UNDER BPA VA797P-15-A-0006 FOR SUCRAID.
Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2018-12-21+$0$02019 PUBLIC LAW UPDATES

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI M1NNLZQB9HA5)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0837245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$16,945FY2026
36C24526N0730245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$25,418FY2026
36C24526N0475245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$33,890FY2026
36C24526N0184245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$32,900FY2026
36C24925F0100249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$16,450FY2025
36C24925F0059249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$32,426FY2025

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA797P15A0006_3600 · retrieved 2026-09-26.